Resources

29 Resources for

biotech and trader mark

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

Emergent BioSolutions: Stellar Acting Stock
Trader Mark submits: I asked readers last week if they had any stocks on their screens that fulfilled some criteria in this quite brutal marketI am curious on your watch lists and holdings if you technical types out there can find stocks over both their 50 and 200 day moving...
Tags: Trader, Stock, Emergent Biosolutions, Seeking Alpha, Trader Mark, Investment, Finance, Biotech
External links 2008-10-22
Sequenom Misses, but Who Cares?
Trader Mark submits: Near term results for Sequenom SQNM are really a moot point as we're looking to mid 2009 forward on this story; the main issue in this new and not so improved environment is making sure young companies have cash to get them to the point where they...
Tags: Trader, Biotechnology Company, Seeking Alpha, Trader Mark, Biotechnology, Sequenom Inc., Biotech
External links 2008-10-30
Emergent BioSolutions' Blowout Quarter
Trader Mark submits: I almost bought Emergent BioSolutions EBS today on the pullback to support (20 day moving average) to fill my 2 stock "government as customers" portfolio - but with earnings tonight I wanted to hold off. And what an earnings they are - EBS should be on Jimmy...
Tags: Revenue, Net Income, Analyst, Emergent Biosolutions, Seeking Alpha, Trader Mark, Sales Strategy, Operational Accounting, Product Development, Sales, Finance, Research & Development, Business Operations, Biotech
External links 2008-11-06
Emergent BioSolutions Files Shelf Registration
Trader Mark submits: One of the few stocks with a chart worth buying is down 12% today on a shelf registration of "up to" $100M. This is too bad since it's an overhang for now, especially for a company of only $600M in market cap - that is potentially some...
Tags: Registration Statement, Emergent Biosolutions, Common Stock, Seeking Alpha, Shelf Registration, Trader Mark, Biotech
External links 2008-11-13
Emergent BioSolutions Looking Strong, Even on a Bad Day
Trader Mark submits: Investors Business Daily has an article out on Emergent BioSolutions EBS that could read straight out of this blog - namely, it has a customer whose pockets are endless and a long sight line on revenue a rarity in this market. Remember, we have two names who...
Tags: Biotech, Trader Mark, Emergent Biosolutions
External links 2008-12-01
Starting to Rebuild Genoptix
Trader Mark submits: Genoptix GXDX broke its 200 day moving average just over a week ago after being one of the last holdouts holding above .. .that was at $31. In this market, when you break support, you die a quick death - it's now down to $26. This stock...
Tags: Biotech, Trader Mark
External links 2008-12-03
Until Proven Otherwise, Sticking with Emergent BioSolutions
Trader Mark submits: We said in our weekly missive we want to buy the best charts on buybacks and Emergent BioSolutions EBS is giving us a nice opportunity to add at the 20 day moving average (around $23.70). I am going to do so, but give a very large caveat...
Tags: Biotech, Trader Mark, Emergent Biosolutions
External links 2008-12-30
Emergent Biosolutions Acquisition Is Dead, Stock Fairly Stable
Trader Mark submits: I am surprised this news has not hit the stock harder - FluBlok was a potential catalyst for Emergent BioSolutions EBS in the future. This has been a contentious acquisition from day 1, but now appears completely dead. Stick a fork in it.Emergent Biosolutions said...
Tags: Biotech, Trader Mark, Emergent Biosolutions
External links 2009-01-09
Deja Vu: Intuitive Surgical Back to 2005 Levels
Trader Mark submits: Buy and hold investing has simply been obliterated in the U.S. the past decade. I found Intuitive Surgical ISRG in 2005 and started buying it in the $40s area, eventually unloading my stake in the $90-$110 range. It jumped to around $130 in early 2006 before...
Tags: Biotech, Trader Mark, Intuitive Surgical Inc.
External links 2009-01-09
Exact Sciences Plays Hard to Get with Sequenom
Trader Mark submits: I've asked mother market to drop Sequenom SQNM to $21 so I can reload the position - a bevy of limit orders waiting. Missed it by THAT much....Remember this will be a news event driven stock - end of January test results will cause a quite...
Tags: Biotech, Healthcare, Trader Mark, EXACT Sciences Corp., Sequenom Inc.
External links 2009-01-14
Myriad Genetics - A Diagnostics Heavy Hitter
Trader Mark submits: Along with Sequenom SQNM, another name I've been watching for quite a while in the healthcare diagnostic area is Myriad Genetics MYGN. Both were mentioned in a blog entry from August 2008 [Aug 25: Sequenom Flying off a Positive Investor's Business Daily Mention]. Their niche is...
Tags: Biotech, Trader Mark, Myriad Genetics Inc.
External links 2009-01-21
Myriad's Monster Results
Trader Mark submits: Myriad Genetics MYGN has been a name I had been hoping to buy on a pullback closer to mid $60s [Jan 20: Myriad Genetics - Another Diagnostic Heavy Hitter] - but it refused to fall during this multi-week correction in the general market. Now we see...
Tags: Biotech, Trader Mark, Myriad Genetics Inc.
External links 2009-02-04
Sequenom Misses Earnings Again
Trader Mark submits:Sequenom SQNM reported Tuesday night, but as I said last quarter [Oct 30: Sequenom Misses But We Don't Really Care], and will say next quarter and the quarter after that ... earnings "today" don't mean diddly in this story. The main focus for Sequenom for now is cash...
Tags: Biotech, Trader Mark, Sequenom Inc.
External links 2009-02-12
Thoratec's HeartWare Acquisition May Miss a Beat
Trader Mark submits:Thoratec THOR made an acquisition Friday, in which it stated would impair earnings through 2011.Heart device maker Thoratec Corp. said Friday it agreed to buy HeartWare International Inc. of Australia for $282 million in cash and stock. Pleasanton, Calif.-based Thoratec said half the price will be paid in...
Tags: Biotech, Trader Mark, Thoratec Corp.
External links 2009-02-17
Emergent Biosolutions - Yet Another Failed Breakout
Trader Mark submits:If I had a nickel for every failed breakout the past 9 months, I could start my own mutual fund. Emergent BioSolutions EBS is the latest in a long list. We had warned about the potential when we layered in some long exposure last Friday The...
Tags: Biotech, Trader Mark, Emergent Biosolutions
External links 2009-02-19
Kendle: I'm Glad I Didn't Buy the Chart
Trader Mark submits: Kendle KNDL is not a name we've talked about much of late - I only had a 0.2% stake and I am going to close it out for a whopping $43 gain. The company reported earnings Wednesday morning and there was a 1x issue...
Tags: Biotech, Trader Mark, Kendle International Inc.
External links 2009-02-25
Illumina Sales Light Its Fire
Trader Mark submits: Looks like a very nice batch of gene analyzing systems sold by Illumina ILMN - I saw this news yesterday but with earnings coming next week, I did not want to add to the position ahead of earnings due to the kneejerk reactions that happen. But it's...
Tags: Biotech, Trader Mark, Illumina Inc.
External links 2009-04-17
Trying to Figure out What Illumina Is Telling Us
Trader Mark submits: I am going to be in deep dive with earnings the next few weeks... ah fundamentals, I miss talking about those. Today alone is a monster undertaking [Flood of Earnings Begin - Monday/Tuesday Preview], so I'll be working under candlelight deep into the night trying to find...
Tags: Biotech, Trader Mark, Illumina Inc.
External links 2009-04-21
Rethinking Myriad after 'Those in the Know' Have Left
Trader Mark submits:As always, you can tell a lot from the stock price action ahead of earnings because in the nearly SEC-free Wild Wild West atmosphere "those in the know" act before you will. Myriad Genetics MYGN has been weak for the past two weeks, falling below the 50 day...
Tags: Biotech, Trader Mark, Myriad Genetics Inc.
External links 2009-05-04
Why I'm Exiting Myriad Genetics
Trader Mark submits: Today's action in Myriad Genetics MYGN as discussed last night [Myriad Genetics Slight Miss on Revenue, Beats on Earnings] would put it below the 200 day moving average. I rarely like to add to stocks below that level, and with my smallish position, I am going to...
Tags: Biotech, Trader Mark, Myriad Genetics Inc.
External links 2009-05-05
advertisement
advertisement